:

Ruiping Zhao1, Ruichen Fan2, Yan Pan1

  • 1Department of Nephrology, the First Affiliated Hospital of Bengbu Medical University, Bengbu, China.

BMC nephrology
|May 18, 2024
PubMed
概括

弗鲁昆丁尼布是一种VEGFR抑制剂,可能导致脏限制性血栓性微血管病变 (TMA),这是罕见的癌症治疗并发症. 通过蛋白尿监测和活检进行早期检测对于接受抗VEGF治疗的患者至关重要.